Summarized by Masters of Longevity from Fight Aging!.
Reports on engineered extracellular vesicles that were modified for brain targeting and tested for therapeutic effects in an Alzheimer's mouse model.
Key Takeaways
- RVG-29 peptide was conjugated to young plasma-derived exosomes to create RVG-EXOs for enhanced neuron targeting.
- RVG-EXOs improved spatial learning, working memory, and novel object recognition in 3xTg Alzheimer’s mice.
- RVG-EXOs promoted amyloid-β clearance, reduced Tau hyperphosphorylation, and activated autophagy by inhibiting RPTOR expression.
